Scientific Reports (Jul 2023)

A comparison of different machine-learning techniques for the selection of a panel of metabolites allowing early detection of brain tumors

  • Adrian Godlewski,
  • Marcin Czajkowski,
  • Patrycja Mojsak,
  • Tomasz Pienkowski,
  • Wioleta Gosk,
  • Tomasz Lyson,
  • Zenon Mariak,
  • Joanna Reszec,
  • Marcin Kondraciuk,
  • Karol Kaminski,
  • Marek Kretowski,
  • Marcin Moniuszko,
  • Adam Kretowski,
  • Michal Ciborowski

DOI
https://doi.org/10.1038/s41598-023-38243-1
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 14

Abstract

Read online

Abstract Metabolomics combined with machine learning methods (MLMs), is a powerful tool for searching novel diagnostic panels. This study was intended to use targeted plasma metabolomics and advanced MLMs to develop strategies for diagnosing brain tumors. Measurement of 188 metabolites was performed on plasma samples collected from 95 patients with gliomas (grade I–IV), 70 with meningioma, and 71 healthy individuals as a control group. Four predictive models to diagnose glioma were prepared using 10 MLMs and a conventional approach. Based on the cross-validation results of the created models, the F1-scores were calculated, then obtained values were compared. Subsequently, the best algorithm was applied to perform five comparisons involving gliomas, meningiomas, and controls. The best results were obtained using the newly developed hybrid evolutionary heterogeneous decision tree (EvoHDTree) algorithm, which was validated using Leave-One-Out Cross-Validation, resulting in an F1-score for all comparisons in the range of 0.476–0.948 and the area under the ROC curves ranging from 0.660 to 0.873. Brain tumor diagnostic panels were constructed with unique metabolites, which reduces the likelihood of misdiagnosis. This study proposes a novel interdisciplinary method for brain tumor diagnosis based on metabolomics and EvoHDTree, exhibiting significant predictive coefficients.